2026. Skin manifestations associated with Glucagon-Like Peptide-1 (GLP-1) receptor agonist use for weight loss: A cross-sectional analysis. Journal of Pakistan Association of Dermatologists. 36, 1 (Mar. 2026), 3–9. DOI:https://doi.org/10.66344/jpad.v36i1.3221.